Today is World Health Day, and to celebrate GOLD asked Claire Gillis, CEO, VMLY&R Health, to share her thoughts on using creativity to create better access to healthcare for all

Now that the world has had time to see the risks and rewards of ChatGPT, pharma industry must decide whether to take it or leave it. Read for more.

Digital therapeutics are making their way onto the main stage, and pharma should be taking note. What lies ahead for potential partnerships?

GOLD explores what the pharmaceutical industry’s future might look like with the adoption of blockchain technology within its key functions.

Technology has redefined the exchange of health information. Find out how the pharma industry can help patients build confidence about digital health tools.

Europe is a front runner for pharmaceutical research and thought leadership Find out in what measure this is translating into home-grown innovation.

The pharmaceutical supply chain is vulnerable to adverse events, and the pandemic has served as a reminder of how these networks can be tested. The industry has learned tough lessons from COVID-19 that must be translated into modernisation and improvements

The pandemic revived all areas of vaccine development. Read more about the effect of Covid-19 on investment, development and commercialisation of vaccines.